Literature DB >> 20414318

Growth and development: how safe is growth hormone therapy for children?

Steven D Chernausek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20414318     DOI： 10.1038/nrendo.2010.43

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  8 in total

1.  Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society.

Authors: 
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

2.  Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.

Authors:  S E Hankinson; W C Willett; G A Colditz; D J Hunter; D S Michaud; B Deroo; B Rosner; F E Speizer; M Pollak
Journal:  Lancet       Date:  1998-05-09       Impact factor: 79.321

3.  Leukaemia in patients treated with growth hormone.

Authors: 
Journal:  Lancet       Date:  1988-05-21       Impact factor: 79.321

4.  Recent status in the occurrence of leukemia in growth hormone-treated patients in Japan. GH Treatment Study Committee of the Foundation for Growth Science, Japan.

Authors:  Y Nishi; T Tanaka; K Takano; K Fujieda; Y Igarashi; K Hanew; T Hirano; S Yokoya; K Tachibana; T Saito; S Watanabe
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

Review 5.  Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis.

Authors:  Mari-Anne Rowlands; David Gunnell; Ross Harris; Lars J Vatten; Jeff M P Holly; Richard M Martin
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

6.  Long-term safety of recombinant human growth hormone in children.

Authors:  J Bell; K L Parker; R D Swinford; A R Hoffman; T Maneatis; B Lippe
Journal:  J Clin Endocrinol Metab       Date:  2009-11-11       Impact factor: 5.958

Review 7.  Does the GH-IGF axis play a role in cancer pathogenesis?

Authors:  P Cohen; D R Clemmons; R G Rosenfeld
Journal:  Growth Horm IGF Res       Date:  2000-12       Impact factor: 2.372

8.  Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor.

Authors:  Berrin Ergun-Longmire; Ann C Mertens; Pauline Mitby; Jing Qin; Glenn Heller; Weiji Shi; Yutaka Yasui; Leslie L Robison; Charles A Sklar
Journal:  J Clin Endocrinol Metab       Date:  2006-07-05       Impact factor: 6.134
  8 in total
  1 in total

Review 1.  The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects.

Authors:  Farhad Dehkhoda; Christine M M Lee; Johan Medina; Andrew J Brooks
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-13       Impact factor: 5.555
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.